Type 2 Inflammation in Asthma and COPD: Biomarkers, Clinical Applications, and Targeted Therapies. [PDF]
Dou M, Zhang X, Zhang M.
europepmc +1 more source
Precision targeting of type 2 inflammation in COPD: identifying candidates for dupilumab therapy. [PDF]
Zhong K, Lv K, Liang Q.
europepmc +1 more source
Short-term longitudinal variation in exhaled nitric oxide fraction predicts future moderate-to-severe exacerbations in COPD patients on triple therapy: a prospective cohort study. [PDF]
Gong Z +12 more
europepmc +1 more source
Association of airway CCL28 with type 2 inflammation and secretory IgA in patients with asthma. [PDF]
Jiang X +7 more
europepmc +1 more source
Real-world effectiveness and clinical outcomes of biologic therapy in severe asthma: A single-center experience from the United Arab Emirates. [PDF]
Ayoob MA, Al Mazrooei KAS, Al Nahdi NSA.
europepmc +1 more source
Treatment Impact on Inflammatory Markers in Patients with Asthma and Allergic Bronchopulmonary Aspergillosis. [PDF]
Saxena P, Muthu V, Sehgal IS, Agarwal R.
europepmc +1 more source
Domiciliary fractional exhaled nitric oxide predicts exacerbation risk and guides ICS tapering in controlled asthma. [PDF]
Liu W +7 more
europepmc +1 more source
Reply to Zhao et al.: Clarifying structural-functional coupling by FeNO status in VESTIGE. [PDF]
Dunican EM +10 more
europepmc +1 more source
Association between combined allergic rhinitis and asthma syndrome in children and nitric oxide: mechanisms, clinical significance, and research progress. [PDF]
Chen K, Lin H.
europepmc +1 more source
Nonadherence to inhaled corticosteroids is associated with negative mepolizumab response. [PDF]
Almutairi MG +10 more
europepmc +1 more source

